Amgen to buy Horizon Therapeutics in $26.4 billion deal
Amgen will acquire Horizon Therapeutics, which focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4
Read moreAmgen will acquire Horizon Therapeutics, which focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4
Read moreNames on the move ahead of the open. Source link
Read moreNames on the move ahead of the open. Source link
Read moreFor many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga. Source link
Read moreLooking for some predictability right now? CNBC PRO has screened for low-volatility stocks with income in the U.S. and beyond.
Read moreInvestors seeking returns in a beaten-down market could turn to companies buying back their shares. Goldman names the stocks it
Read moreThese are the stocks posting the largest moves in midday trading. Source link
Read moreBernstein has named a raft of global stocks that it says could benefit from the rising strength of the U.S.
Read moreCNBC identified buy-rated stocks from the U.S. and beyond that have a track record of stability when markets are going
Read more